Stock listing

NASDAQ:BBNX Beta Bionics, Inc. Stock

Home listing (NASDAQ) of Beta Bionics, Inc.

Follow Beta Bionics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:BBNX

$17.85 USD -3.54 (-16.5%)

Close on Oct 28, 2026

Past year -26.5% · daily closes, Oct 28, 2025 – Oct 28, 2026, adjusted for splits
Day range
$17.15 – $20.07 USDOct 28, 2026
Volume
2.80M sharesOct 28, 2026
Market cap
$962.9M USDAt the close on Oct 28, 2026 · price × 53.95M shares outstanding
52-week range
$8.80 – $32.71 USDLowest and highest trades, Oct 29, 2025 – Oct 28, 2026
Traded on an average day
$24.32M USDMedian day 975,200 shares · last 3 months, Jul 28, 2026 – Oct 28, 2026
Beta Bionics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:BBNX · Home$17.85 USD-3.54 (-16.5%)2,798,372$18.93$20.07$17.15$21.39Close on Oct 28, 2026

Daily closes

Last 3 months, Jul 28, 2026 – Oct 28, 2026 · NASDAQ:BBNX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$17.85-3.54-16.5%$18.93$20.07$17.152,798,372
$21.39+0.88+4.3%$20.50$22.29$20.401,363,379
$20.51+1.35+7.0%$19.08$21.19$19.081,630,969
$19.16-0.18-0.9%$19.38$19.54$18.81827,847
$19.34+0.94+5.1%$18.40$19.38$18.23685,201
$18.40+0.66+3.7%$17.79$18.50$17.171,440,594
$17.74+0.90+5.3%$16.98$18.06$16.87656,725
$16.84+0.49+3.0%$16.60$17.39$16.601,684,844
$16.35-0.96-5.5%$17.42$17.53$16.32660,800
$17.31+0.44+2.6%$16.98$17.60$16.601,331,100
$16.87-0.82-4.6%$17.35$17.54$16.72892,900
$17.69-0.17-1.0%$17.87$18.14$17.52591,200
$17.86+0.23+1.3%$17.94$18.56$17.71820,700
$17.63+0.20+1.1%$17.47$17.88$17.12955,100
$17.43-0.65-3.6%$17.96$18.04$17.071,113,800
$18.08-0.55-3.0%$18.91$19.11$17.931,531,200
$18.63-0.32-1.7%$18.91$19.24$18.31922,800
$18.95-0.01-0.1%$18.91$19.27$18.74624,600
$18.96+0.09+0.5%$18.87$19.26$18.27515,100
$18.87-0.11-0.6%$19.35$19.44$18.391,137,500
$18.98-0.43-2.2%$19.22$19.52$18.451,456,300
$19.41-1.11-5.4%$20.61$20.73$19.28842,500
$20.52-0.99-4.6%$21.50$21.70$19.931,760,500
$21.51-0.25-1.1%$21.74$21.98$21.25926,000
$21.76-0.43-1.9%$22.31$22.62$21.44906,800
$22.19-0.62-2.7%$23.00$23.48$21.881,396,300
$22.81+0.77+3.5%$22.18$23.56$22.10999,600
$22.04+0.15+0.7%$22.11$22.48$21.78783,300
$21.89+0.46+2.1%$21.30$22.16$21.101,529,000
$21.43-0.75-3.4%$22.46$22.66$20.393,090,300
$22.18+2.95+15.3%$18.61$22.22$18.407,191,200
$19.23+2.50+14.9%$16.73$19.55$16.371,694,200
$16.73+0.16+1.0%$15.52$17.60$15.511,805,500
$16.57-0.02-0.1%$16.59$16.71$15.85726,100
$16.59-0.83-4.8%$17.60$17.95$16.50957,700
$17.42-1.91-9.9%$19.14$19.54$17.26848,100
$19.33-0.09-0.5%$19.18$19.52$18.75900,800
$19.42-0.50-2.5%$19.55$19.97$19.001,407,500
$19.92+0.505+2.6%$19.90$20.19$19.031,403,500
$19.42+0.345+1.8%$18.99$19.57$18.91645,100
$19.07-0.88-4.4%$19.75$20.23$18.93564,400
$19.95+0.23+1.2%$19.42$20.00$19.02434,900
$19.72+0.18+0.9%$19.47$20.07$19.25992,700
$19.54+0.20+1.0%$19.22$19.64$19.12518,700
$19.340.000.0%$19.16$19.44$19.01529,800
$19.34-0.39-2.0%$19.92$20.00$18.62710,957
$19.73+0.68+3.6%$18.97$19.85$18.47864,533
$19.05-0.43-2.2%$19.50$19.54$18.54496,500
$19.48-0.53-2.6%$20.00$20.74$18.481,933,800
$20.01+0.99+5.2%$19.30$20.38$19.301,947,600
$19.02+1.46+8.3%$17.56$19.08$17.501,976,000
$17.56-0.01-0.1%$17.31$17.67$16.991,267,700
$17.57-0.51-2.8%$18.12$18.15$17.49935,900
$18.08+0.75+4.3%$17.33$18.33$17.041,503,000
$17.33-0.29-1.6%$17.52$17.52$16.76637,900
$17.62+1.22+7.4%$16.55$17.64$16.15613,918
$16.40+0.50+3.1%$15.66$16.86$15.641,316,058
$15.90+1.79+12.7%$14.18$16.58$14.071,274,300
$14.11+0.20+1.4%$13.72$14.23$13.62590,200
$13.91-0.66-4.5%$14.59$14.68$13.70897,000
$14.57+1.22+9.1%$13.35$14.58$13.333,341,400
$13.35+0.52+4.1%$12.83$13.91$12.732,820,100
$12.83-1.44-10.1%$13.99$14.28$12.792,004,600
$14.27-0.90-5.9%$15.97$16.44$13.553,195,700
$15.17-0.63-4.0%$15.65$15.96$14.961,673,600
$15.80-0.19-1.2%$16.29$16.37$15.59660,100
Ticker
NASDAQ:BBNX
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Beta Bionics (NASDAQ:BBNX) Q3 2026 Earnings Call

    Tue, Oct 27, 2026 · 4:30 PM ET

    Watch Transcript

  • Beta Bionics (NASDAQ:BBNX) Q2 2026 Earnings Call

    Wed, Jul 29, 2026 · 4:30 PM ET

    Watch Transcript

  • Beta Bionics (NASDAQ:BBNX) Q1 2026 Earnings Call

    Tue, Apr 21, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Beta Bionics Announces Third Quarter 2026 Financial Results and Updates Full Year 2026 Guidance

Oct 27, 2026

Closed $17.85 (-16.5%) on Oct 28, 2026

Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BBNX

Oct 5, 2026

Closed $18.95 (-0.1%) on Oct 5, 2026

Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026

Sep 29, 2026

Closed $19.41 (-5.4%) on Sep 29, 2026

Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365

Sep 22, 2026

Closed $22.81 (+3.5%) on Sep 22, 2026

Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock

Sep 17, 2026

Closed $21.89 (+2.1%) on Sep 18, 2026

Beta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Sep 15, 2026

Closed $22.18 (+15.3%) on Sep 16, 2026

Beta Bionics Announces Proposed Public Offering of $125.0 Million of Common Stock

Sep 15, 2026

Closed $22.18 (+15.3%) on Sep 16, 2026

Beta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm

Sep 14, 2026

Closed $16.73 (+1.0%) on Sep 14, 2026

Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance

Jul 29, 2026

Closed $14.27 (-5.9%) on Jul 30, 2026

Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026

Jul 1, 2026

Closed $16.70 (+6.6%) on Jul 1, 2026

All Beta Bionics, Inc. news

Financings

  • Public offering of common stock and pre-funded warrants

    Sep 17, 2026

    Closed: US$172.5M raised · US$17.25 a share · J.P. Morgan +3

    Dealers: J.P. Morgan (co-lead), Piper Sandler (co-lead), Wells Fargo Securities (co-lead), Leerink Partners (co-lead)

    Use of proceeds: General corporate purposes, including commercialization of Mint, manufacturing expansion, R&D and clinical development, and working capital

    Announced Sep 15, 2026 · Closed Sep 17, 2026

Read by 6ix AI from the company's releases

Decks

Beta Bionics, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
21 in the last 12 months · 36 in all · newest Oct 27, 2026 · oldest 2025
Calls
7 calls with a replay · 7 with a transcript · latest Oct 27, 2026
Decks
10 decks · latest Oct 27, 2026

Where Beta Bionics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:BBNX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:BBNXBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Beta Bionics, Inc.